Ocular drug delivery mode is a technique of treating the eye locally. Global Ocular Drug Delivery Mode Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Ocular Drug Delivery Mode market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Ocular Drug Delivery Mode Market Analysis, 2020”, the Global Ocular Drug Delivery Mode market is anticipated to grow at a CAGR of around 7.5% during 2020-25F. Based on the formulation type, solutions acquired a considerable market share in 2019 owing to its cost-effectiveness, high-patient compliance, and increasing production volume.
Topical Iontophoresis Exhibited Subsequent Growth
Topical Iontophoresis exhibited subsequent growth in the forecast period on account of easy accessibility and the launch of new products with this technology. Moreover, various companies are increasing their presence through mergers and acquisitions of new firms which is expected to proliferate the growth of Ocular Drug Delivery Mode market.
Hospitals Acquired Considerable market share
Based on end user, hospitals acquired the considerable market share in 2019. The rising number of surgeries for eye disorders such as cataract, glaucoma, etc., and burgeoning healthcare spending in the countries such as United States and Canada are anticipated to actively contribute toward the growth of the Ocular Drug Delivery Mode market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Ocular Drug Delivery Mode Market Analysis, 2020”.